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Abstract
Kelch-like ECH-associated protein 1 (Keap1) is an inhibitor of nuclear factor
erythroid 2-related factor 2 (Nrf2), a key transcription factor for cytoprotective gene
activation in the oxidative stress response. Under unstressed conditions, Keap1 interacts
with Nrf2 in the cytoplasm via its Kelch domain and suppresses the transcriptional
activity of Nrf2. During oxidative stress, Nrf2 is released from Keap1 and is translocated
into the nucleus, where it interacts with the small Maf protein to initiate gene
transcription. Prothymosin alpha (ProTα), an intrinsically disordered protein, also
interacts with the Kelch domain of Keap1 and mediates the import of Keap1 into the
nucleus to inhibit Nrf2 activity. To gain a molecular basis understanding of the oxidative
stress response mechanism, we have characterized the interaction between ProTα and the
Kelch domain of Keap1 by using nuclear magnetic resonance spectroscopy (NMR),
isothermal titration calorimetry (ITC), peptide array analysis, site-directed mutagenesis,
and molecular dynamic (MD) simulations. The results of NMR chemical shift mapping,
amide hydrogen exchange, and spin relaxation measurements revealed that ProTα retains
a high level of flexibility, even in the bound state with Kelch. This finding is in
agreement with the observations from the MD simulations of the ProTα-Kelch complex.
Mutational analysis of ProTα, guided by peptide array data and ITC, further pinpointed
that the region 38NANEENGE45 of ProTα is crucial for the interaction with the Kelch
domain, while the flanking residues play relatively minor roles in the affinity of binding.
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Introduction
Prothymosin α (ProTα) is a 12-kDa acidic protein with multiple biological functions13

. It is highly conserved in mammals, is widely distributed in various tissues, and has a

distinct amino acid composition1-3. Its protein sequence lacks aromatic and Cys residues,
and about 50% of the sequence is composed of either Glu or Asp. These acidic residues
are mostly localized in the center of the protein sequence1-5. A nuclear localization signal,
TKKQK, exists in the C-terminal region6,7. Early studies of ProTα had shown that the
protein is unstructured under non-denaturing conditions but can adopt a partially folded
conformation at acidic pH 8,9. We have extensively characterized the structural and
dynamic properties of this protein under physiological buffer conditions by using nuclear
magnetic resonance (NMR) spectroscopy and electrospray ionization mass spectrometry
(ESI-MS)10. The results clearly demonstrated that ProTα is largely disordered and
extremely dynamic, with only a slight propensity for β-strand structure. However, the
protein can adopt more compact conformations upon binding to zinc ions10,11.
ProTα is an oncoprotein expressed at high levels in proliferating cells. It increases
cell proliferation by shortening the G1 phase of the cell cycle12. Studies have shown that
in the absence of ProTα, cells undergo apoptosis or are unable to divide13-15. ProTα also
binds histones4,16-18, plays a role in chromatin remodeling16,19, acts as a transcription
activator through CREB binding protein20,21, prevents formation of the apoptosome22-25,
and facilitates movement of charged particles within the nucleus and surrounding
environment26. Further, the protein suppresses HIV-1 by inducing production of type 1
interferon27-29, plays a neuroprotective role after ischemic events30,31, and functions as a
tumor-associated protein in human colon cancer, lung cancer, urinary tract cancer, and
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breast cancer32-36. Recent studies have shown that ProTα also has an important role in the
oxidative stress response37,38.
Cells are constantly attacked by reactive oxygen species, electrophiles,
carcinogens, and xenobiotics39,40. Pathological conditions, such as neurodegenerative
diseases, arthritis, cancer, and cardiovascular diseases, can arise if cells fail to counteract
oxidative stress by inducing cytoprotective gene expression39-43. Nuclear factor erythroid
2-related factor 2 (Nrf2) is one of the key regulators of the cellular responses to oxidative
stress40,44,45. Nrf2 is a bZIP transcription activator of cytoprotective genes40,44. The
protein is composed of six domains, Neh1 to Neh646. The N-terminal Neh2 domain,
which is intrinsically disordered47, is involved in maintaining homeostatic levels of Nrf2
through binding to Keap1 (Kelch-like ECH-associated protein 1)46. Keap1, an adaptor
protein in the Cul3-based E3 ubiquitin ligase complex48, is composed of five distinct
regions as follows: i) N-terminal region, ii) BTB (Broad complex, Tramtrack, and Bric-aBrac), iii) IVR (intervening region), iv) DGR (double glycine repeat), and v) C-terminal
region46,48. The DGR and C-terminal regions of Keap1, known as the Kelch domain, form
a six-bladed β-propeller structure, which harbors the binding site of the Neh2 domain of
Nrf249.
Under basal cellular conditions, the Neh2 domain of Nrf2 interacts with the Kelch
domains of the Keap1 dimer via the ETGE and DLG motifs47,50. This interaction results
in ubiquitination and ultimately, the degradation of Nrf248. When the cell is under
oxidative stress, Keap1 is no longer able to bind Nrf2 and the latter is translocated to the
nucleus, where it interacts with the small Maf protein to activate transcription of
cytoprotective genes40.
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ProTα plays a crucial role in the Nrf2 signaling pathway by mediating the nuclear
import of Keap1/Cul3-Rbx1 in order to lower Nrf2 levels in the nucleus, allowing the cell
to return to normal conditions38,51. Once in the nucleus, ProTα dissociates from the
Keap1/Cul3-Rbx1 complex, allowing Nrf2 to bind to the complex for degradation38,51.
The interaction between mouse ProTα and Keap1 has been studied previously.
Using the yeast two hybrid system and different protein constructs, amino acids 32 to 52
in the mouse ProTα have been identified to be crucial for the interaction with the Kelch
domain of Keap137. Padmanabhan et al. expanded on these findings by performing
structural analysis on the mouse ProTα-Kelch complex52. A 16-mer peptide composed of
39

AQNEENGEQEADNEVD54 of mouse ProTα was crystallized with the Kelch

domain52. The structure reveals that the negatively charged ProTα peptide binds to the
basic bottom face of the β-propeller structure of Kelch, forming many electrostatic
interactions, especially via the ENGE motif of ProTα. It is noteworthy that the electron
density corresponding to residues 49-54 of the ProTα peptide was missing, suggesting
this part of the peptide may not adopt a stable conformation upon binding to Kelch52.
Compared to the structures of Neh2-Kelch52-54, the EENGE motif of ProTα and the
EETGE motif in the Neh2 domain bind to the same site on the Kelch domain52.
Although ProTα has multiple biological functions and many targets, very limited
structural information about this disordered protein is available, especially concerning its
target interactions. The crystallographic study of ProTα-Kelch peptide-protein complex is
the only detailed structural characterization of ProTα in a bound-state form52. However,
the molecular mechanism by which full-length ProTα binds to Kelch remains unclear.
Many disordered proteins undergo disorder-to-order transition upon binding to their
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targets55-57. These protein-protein interactions are frequently enthalpy driven because the
loss of conformational freedom of an intrinsically disordered protein (IDP) upon target
binding is usually significant, with a resulting unfavorable entropy change57-61. IDPs can
also interact with targets via preformed structural elements, perhaps lessening the entropy
loss and modulating the affinity of binding62-66. Intriguingly, some IDPs remain
disordered even in complexes with targets67-69. Due to the crucial roles ProTα and Keap1
have in the oxidative stress response, in this study, we used experimental and
computational approaches to delineate the molecular basis of their binding. The result
will not only lead to a better understanding how these two proteins function in the Nrf2
pathway, it will also provide insight into designing drugs that specifically target the
interactions between Keap1 and its disordered partners70-74.
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Results
Mapping the Kelch-binding region on ProTα by NMR spectroscopy
The Keap1-binding region on the full-length human ProTα was identified by
using NMR spectroscopy. A two-dimensional 1H-15N heteronuclear single quantum
coherence (HSQC) spectrum of 15N-labeled ProTα was collected (Fig. 1a). The lack of
chemical shift dispersion in the 1H dimension of the spectrum indicates that the protein
was intrinsically disordered in the absence of Kelch. This finding agrees qualitatively
with the disorder predictions of ProTα by PONDR-FIT75 and metaPRDOS76 (Fig. S1),
suggesting that the protein is largely unstructured. These results are also consistent with
our previous structural characterization of ProTα carried out in a buffer with lower ionic
strength 10,77. Potential binding regions of disordered ProTα were also predicted by using
ANCHOR78, and MoRFpred79. Based on the protein sequence, ANCHOR predicted that
the binding sites of ProTα are scattered throughout a large part of the sequence (residues
1-57 and 76-99), whereas MoRFpred anticipated that the molecular recognition features
of ProTα are specifically located between residues 38-61 (Fig. S1).
To precisely determine the Kelch-binding region on ProTα, changes in the
chemical environment of ProTα upon binding to the Kelch domain were then probed by a
series of 1H-15N HSQC experiments acquired with increasing concentrations of unlabeled
Kelch (Fig. 1a). Additions of Kelch led to the perturbations of several ProTα backbone
1

H/15N resonances. Significant chemical shift changes or attenuations in peak intensity

were observed for N36, G37, N38, A39, N40, N43, G44, D49, and N50, as well as
several unassigned residues10. Notably, the dispersion of NMR signals in the 1H
dimension remained very narrow, indicating that ProTα did not undergo global disorder-
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to-order transition upon binding to the Kelch domain of Keap1. Aside from the resonance
changes mentioned above, most of the peaks in the 1H-15N HSQC spectra remain
unchanged in position. This result strongly suggests that the dynamic nature of the rest of
ProTα was retained upon target binding.
To identify the conformational changes of ProTα induced by the binding of
Kelch, backbone 13Cα/β chemical shifts were analyzed using the residue-specific
secondary structure propensity (SSP) program80. Based on the differences between the
observed chemical shifts and random coil values, a single score between 1 and -1, which
is indicative of stable α-helical structure and β-strand structure, respectively, was
assigned to each residue. SSP scores of ProTα in the absence and presence of Kelch were
compared. The result (Fig. 1b) shows that moderate changes occurred in SSPs of ProTα
in the segment spanning residues 36-52; however, the rest of the protein had similar SSP
scores in the absence and presence of Kelch. Notably, in the bound state, amino acids in
region 35-53 had SSP scores ranging only from -0.34 to 0.17, indicating a lack of stable
secondary structure in this region.
Changes in the chemical environment of Kelch upon binding to ProTα were also
monitored by HSQC experiments. In the presence of two molar equivalents of the fulllength ProTα, many resonance signals of the Kelch domain display noticeable changes in
chemical shift or significant decreases in intensity. The same set of peaks are perturbed in
the presence of two molar equivalents of the ProTα peptide spanning residues 33-52,
albeit to different extents (Fig. S2). Nevertheless, the results clearly illustrate that the fulllength ProTα and peptide bind to the same site on the Kelch domain. Notably, similar
spectral changes were observed for the interaction between the mouse Kelch and Neh2
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peptide74. Resonance signals of the mouse Kelch that showed large chemical shift
changes or intensity attenuations upon binding to the Neh2 peptide were consistent with
the binding interface determined by X-ray crystallography (PDB 1X2R). More detailed
structural and dynamic characterization of the 32-kDa human Kelch domain and its
target-binding by NMR is in progress.

Disordered ProTα forms a fuzzy complex with the Kelch domain of Keap1
To further characterize the dynamic properties of the ProTα-Kelch complex,
backbone 15N spin relaxation and steady-state 1H-15N NOE experiments were performed
on the free and Kelch-bound states of ProTα. These experiments are commonly used in
studying protein dynamics and are particularly valuable for probing motions on the ps-ns
timescale81. Fig. 2 shows the 15N R1, R2, and steady-state 1H-15N NOEs measured for 15Nlabeled ProTα (150 µM) in the absence and presence of 300 µM of unlabeled Kelch.
Forty-three assigned residues (out of the 110 ProTα residues) with well resolved peaks
were included in the data analysis. In the absence of Kelch, all of these 43 residues have
R1 values within a narrow range of 0.87 to 3.13 s-1 (2.45 s-1 in average) (Fig. 2a).
Interestingly, addition of Kelch led to insignificant changes in the R1 values of ProTα
(0.85 – 3.06 s-1, average = 2.47 s-1). In the absence of Kelch, the observed R2 ranged from
0.5 to 5.3 s-1. Notably, for a globular protein with similar molecular weight of ProTα,
residues in structured regions are expected to have R2 ~ 10 s-1 82. Upon addition of Kelch,
small, yet significant, increases in R2 values were observed for most of the residues (Fig.
2b). Larger increases were noted for residues in the region 30-53, which are involved in
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the interaction with Kelch, as identified by the chemical shift mapping result mentioned
in the previous section.
The steady-state 1H-15N NOE is sensitive to fast internal motion, a good indicator
of protein mobility on the ps-ns timescale81,83. Generally, large negative NOE values are
observed in flexible regions of a protein83. In the free state, NOE values of ProTα were
mostly negative, which is consistent with the disordered nature of this protein (Fig. 2c).
In the Kelch-bound state, increases in the NOE values were observed for residues 30 to
59 (-0.49 to 0.17), indicating that this region became more restricted in motion (Fig. 2c).
Notably, for residues in a structured complex of size ~46 kDa, the NOE values are
expected to be ~0.8. Note that the errors of the measurements are significant for those
peaks with NOEs close to zero.
To further investigate the nature of the ProTα-Kelch interaction, we conducted
NMR amide hydrogen exchange experiments to probe the changes in solvent accessibility
of ProTα upon binding to Kelch84. Protection factor, which is defined as the ratio of the
intrinsic to the measured exchange rate, was determined for backbone amides of ProTα
(with isolated signals) in the absence and presence of Kelch (Fig. 3). The low protection
factor values of ProTα (0.3 – 5.5; average of 1.6) in the absence of Kelch indicate that the
backbone amides were largely exposed to solvent, as expected for a highly unstructured
protein like ProTα. Interestingly, no dramatic increases in protection factor values were
observed upon addition of Kelch. Even though moderate increases in protection factor
values for N38, E45, N50, and G60, were observed, these values were significantly
smaller than those observed in folded proteins. For instance, residues located in the
secondary structure elements of lysozyme have amide protection factors of 103-108 85.
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Identifying crucial residues of ProTα for Kelch binding
Permutation peptide arrays were used to examine the roles that individual residues
in ProTα play in the interaction with the Kelch domain. A series of 20-mer peptides,
spanning residues 38-57 of human ProTα, were synthesized on a functionalized cellulose
membrane and then probed with the Kelch protein. Each of the wild-type residues 38-57
was substituted with any of the 19 amino acids (Fig. 4). Cys was excluded in the
permutations to avoid formation of covalent linkages to Kelch during probing, which
would result in false positives. Based on the signal intensities observed in the peptide
array experiments, mutations that significantly attenuated the binding of the ProTα
peptides to Kelch were identified. Many mutations in the 38NANEENGE45 region were
found to be detrimental to Kelch binding, whereas replacing other residues outside this
region had negligible effects on protein-peptide interactions. In particular, mutations of
residues E42, G44, and E45 resulted in loss of interaction with Kelch, indicating that
these three amino acids are critical for the binding. On the other hand, mutation of N43 in
the 42ENGE45 motif to a Thr or Ser enhanced the binding to Kelch.
In the peptide array experiment, the E41P mutation also resulted in a higher
affinity of binding between Kelch and the ProTα peptide. The side chain of E41 forms
hydrogen bonds across the binding interface with Kelch52. Replacing the glutamate in this
position with a non-polar proline was expected to lead to loss of favorable interactions.
Therefore, based on the peptide array result, it was unclear why the E41P mutant of
ProTα displayed a higher affinity to Kelch (see sections in below).
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Quantitative analysis of ProTα and Kelch interaction
To obtain quantitative information for the ProTα-Kelch interaction, isothermal
titration calorimetry (ITC) was used to measure the thermodynamic parameters of
binding. Parameters, including the binding stoichiometry (n), dissociation constant (Kd),
enthalpy change (ΔH), and entropy change (ΔS) of binding, were obtained for the wildtype and a series of mutational variants of full-length ProTα. The results are summarized
in Table 1. To evaluate the contributions of ProTα residues distant from the Kelch
binding motif to the affinity of binding, we first compared the affinity of Kelch to the
full-length ProTα and an 11-mer peptide spanning residues 38-4852. Fig. 5a & b show the
integrated isotherms exhibiting a single-phase curve, which were fitted best to a singlesite binding model. The binding stoichiometry obtained for both the peptide and fulllength protein are close to 1, indicating 1:1 binding between ProTα and Kelch protein.
The result is also in agreement with the stoichiometry derived from sedimentation
equilibrium experiments (Fig. S3).
The dissociation constant of the full-length ProTα-Kelch complex was
determined to be 2.6±0.4 µM by ITC. Interestingly, the 11-mer ProTα peptide bound
slightly tighter (Kd = 1.79±0.09 µM) to Kelch compared to full-length ProTα. Despite the
similar Kd values, the ΔH and ΔS of these two binding processes were very different. The
results (Table 1) indicate a larger entropy loss when the ProTα peptide bound to Kelch.
The more negative ΔS value was compensated for by the more favorable ΔH, resulting in
similar Kd values for both full-length ProTα and its peptide.
The charge complementarity between ProTα and Kelch is crucial for their
interaction. The highly acidic Kelch-binding motif of ProTα binds to the positively
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charged bottom face of the β-propeller structure of Kelch, forming multiple salt bridges
and hydrogen bonds across the interface52. As aforementioned, Karapetian et al.
demonstrated that the E45G/E51G double mutant of ProTα is not capable of binding to
Kelch37. To further delineate the roles that E45 and E51 play in the interface, binding
affinities of the E45G, E45A, E51A, and E51G full-length ProTα mutants to Kelch were
measured. The results show that E45 is critical for the interaction with Kelch, as the
mutation of this residue to Ala or Gly completely abolished the binding to Kelch (Table 1
and Fig. 5f). This observation is consistent with the peptide array result and is in
agreement with the crystallographic data52, which illustrate that the side-chain of E45
forms hydrogen bonds with multiple amino acids on Kelch. Mutations of E51 (Table 1
and Fig. 5i), on the other hand, had little effect on the binding affinity to Kelch,
indicating that this acidic residue plays only a minor role in mediating the interaction of
these two proteins. Our peptide array result clarifies that E45, but not E51, is
indispensable for the protein-protein interaction.
The peptide array result also indicates that the mutation of E47, which is located
close to the 42ENGE45 motif, to any other amino acid (except for R, D, and W) leads to a
decrease in binding affinity to Kelch. Based on the charge complementarity at the ProTα
and Kelch interaction sites, the result of the E47R mutation is unexpected. To validate
this finding, binding affinities of E47R and E47A to Kelch were determined by ITC
(Table 1 and Fig. 5g & h). Results show that while the Ala mutation caused a 55-fold
decrease in the binding affinity to Kelch, the increase in Kd for E47R was less significant
(Kd = 30 µM compared to 2.6 µM for the wild-type).
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E41 is another acidic residue that showed an interesting result in the peptide array
experiment. The crystal structure of the mouse ProTα-Kelch peptide-protein complex
reveals that the side-chain of E41 is involved in hydrogen bonding with Kelch52.
However, mutation of this acidic amino acid to a non-polar proline residue increased the
binding affinity to Kelch (Table 1 & Fig. 5d). ITC measurements confirmed that the
E41P mutant has a more favorable ΔGbind compared to the wild-type ProTα (-8.57
kcal/mol vs. -7.61 kcal/mol; Table 1), mainly due to the less negative value of the ΔS
component.
Based upon the peptide array result, G44 is another residue that is essential for
binding Kelch. To confirm this finding, the binding affinity of the G44A mutant to the
Kelch domain was determined. As expected, no interaction of this mutant with Kelch was
detected by ITC (Fig. 5e). Nevertheless, this specific mutation was very helpful in
validating the backbone assignments around this amino acid. The other two mutants that
were constructed for the same purpose were N36A and D49A. Both mutational variants
bound to Kelch with moderately lower binding affinities (with Kd of 6.5 and 6.7 µM,
respectively), compared to wild-type ProTα (Table 1 & Fig. 5c). We point out that even
though N36 was excluded from the crystallographic study of the peptide-protein complex
of ProTα and Kelch, and the electron density of D49 was absent in the crystal structure
solved52, both the NMR chemical shift perturbations and ITC results indicate that these
two flanking residues also contribute moderately to the binding of ProTα and Kelch.

MD simulations of ProTα-Kelch complex
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Molecular dynamic (MD) simulations were performed on the mouse ProTα-Kelch
and Neh2-Kelch complexes as a complementary approach to probe the dynamics of the
systems (crystal structure of human ProTα-Kelch complex is unavailable thus far). We
had included the Neh2-Kelch complex in this study in order to gain insight into the higher
binding affinity Neh2 has for Kelch. Fig. S4a & b show the snapshots of ProTα and Neh2
in the Kelch-bound states at 50 ns time intervals. To probe the dynamics of ProTα and
Neh2 in their Kelch-bound states quantitatively, circular variances (C.V.) of backbone
torsion angles of residues around the binding regions were extracted from the 300-ns
trajectories. The value of C.V. ranges between 0 and 1. The higher the C.V. value of an
amino acid, the larger is the variability of its torsion angles in the MD simulations. Fig. 6
shows the C.V. of individual amino acids close to the Kelch binding motifs of ProTα and
Neh2. The plots illustrate that ProTα was systematically more dynamic in the bound
state, especially around N38 and G45 (corresponding to N38 and G44 in human ProTα,
respectively). Our previous MD simulations of the free-state mouse ProTα demonstrate
that residues N41-N44 (N40-N43 in human) are located in a flexible region, but with a
propensity of forming a β-turn structure, which is crucial for the bound-state-like βhairpin formation50,65. Interestingly, the C.V. values of N41-N44 observed here in the
bound state are similar to those reported for free state, suggesting that the β-turn structure
formed by N41-N44 is unstable even in the presence of Kelch.
E41 (in human ProTα) is located in the second position of the β-turn structure
mentioned previously. In order to gain insight into the effects of E41P mutation on the βturn propensity in the free-state, 0.5 µs MD simulations of a 16-mer ProTα peptide and
the E41P mutant in explicit solvent were performed (Fig. S5). Fig.7 shows the backbone
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RMSDs of the β-turn between the bound-state structure and the MD conformations
throughout the simulations. The data indicate that even though both the wild-type and
E41P ProTα peptides underwent fast conformational inter-conversion during the MD
simulations (Fig. S5), both peptides frequently sampled lower RMSD (i.e. < 1.0 Å)
bound-state-like conformations. The results suggest that the E41P mutant may still retain
the high tendency of forming a bound-state-like β-hairpin structure around the binding
motif. Despite that these MD simulations provide insight into the conformational
propensities of the wild-type and E41P ProTα peptides, significantly longer trajectories
and more advanced simulation techniques are necessary to further investigate factors that
stabilize the bound-state-like conformations and to improve the convergence65,66.
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Discussion
To better understand the molecular mechanism underlying the oxidative stress
response, in this study, we scrutinized the mechanism by which the intrinsically
disordered ProTα interacts with the Kelch domain of Keap1. Many studies have shown
that IDPs undergo disorder-to-order transition upon binding to their targets through the
coupled binding and folding process55,60. Remarkably, our studies of the ProTα-Kelch
complex have revealed that ProTα retains its disordered nature, even in the bound state.
This finding is supported by the observations that the resonance signals of ProTα in the
1

H-15N HSQC experiments were clustered in a narrow range from 7.9 ppm to 8.6 ppm,

both in the free and bound states (Fig. 1a). Significant chemical shift changes were
observed only for amino acids 35-50. Most of these residues have also been identified as
crucial in mediating the interaction between the mouse homologs of ProTα and
Kelch37,52. The crystal structure of mouse Kelch in complex with a ProTα peptide
spanning amino acids 39-54 (corresponding to residues 38-53 in human) reveals that this
particular segment of ProTα forms a β-turn conformation upon binding to the bottom
side of the β-propeller structure of Kelch52. The binding interface is found to be highly
complementary in charge, with the acidic amino acids in ProTα playing crucial roles in
interacting with multiple Arg residues located on the binding surface of Kelch52. In
particular, the EENGE motif in ProTα (residues 41-45 in human ProTα) was shown to be
essential for the Kelch binding52. Our NMR titration results are in agreement with these
previous findings, and importantly, we show that several other residues flanking the
EENGE motif also display attenuation in resonance signals, indicating they may also be
involved in Kelch binding.
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Compared to the changes in the 1H-15N HSQC of 15N-labeled Neh2 upon binding
to Kelch, the spectral changes observed for free and bound ProTα were less dramatic.
Tong et al. have demonstrated that sharp resonance signals of disordered Neh2 were
severely broadened out upon addition of Kelch47. In the presence of a two molar
equivalents of Kelch, most of the resonance signals of Neh2 disappeared, likely due to
the significant increase in molecular tumbling time through the formation of a large
molecular weight complex or as the result of intermediate conformational exchange
between the free and bound states47. In contrast, the sharpness of resonance signals
prevailed throughout the NMR titration experiments for the majority of residues in
ProTα. Moreover, spin relaxation experiments showed that addition of Kelch led to
insignificant changes in the R1 values of ProTα (0.85 – 3.06 s-1, average = 2.47 s-1).
These observed R1 values are systematically larger than expected for a folded protein
with similar molecular weight of ProTα86,87. For instance, the D39A mutant of the128residue apo-IscU has an averaged R1 value of 1.64 s-1 measured under the same magnetic
field strength and temperature (i.e., 600 MHz; 298 K), while the averaged R1 value of the
105-residue PAH2B domain of mSin3B is 1.45 s-1 (at 293 K)86,87. The higher R1 values
for ProTα are the result of large amplitude of internal motion on the ps-ns timescale in the
protein. Meanwhile, small, yet significant, increases in R2 values were observed for most
of the residues (Fig. 2b) upon addition of Kelch, particularly in the region 30-53. The
increases in R2 suggest that this particular region became more restricted in motion upon
binding to Kelch81. However, the observed R2 values are still significantly smaller than
expected for a 46 kDa (the sum of molecular weights of ProTα and Kelch) complex82.
Further, the NOE values of ProTα remained predominantly negative upon binding to
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Kelch, indicative of a flexible protein lacking secondary structure (Fig. 2c). NOEs of
residues in the region directly involved in forming the binding interface with Kelch
became positive (increases up to 0.17), but these positive values were still significantly
lower than expected for a 46-kDa complex with well-defined structure. Moreover, the
small protection factors determined in the amide exchange experiments are in agreement
with the low R2 and small NOE values observed, suggesting that ProTα forms a dynamic
complex with Kelch.
Peptide array and ITC experiments were conducted to elucidate further the roles
individual amino acids in the binding region of ProTα play in the ‘fuzzy’ interaction with
the Kelch domain. The results are compared to the Neh2-Kelch binding. The binding of
Nrf2 to Keap1 has been described as a “hinge and latch” mechanism50. The disordered
Neh2 domain binds to two Kelch domains of a Keap1 dimer via the N-terminal DLG and
the C-terminal ETGE motifs, respectively. It has been proposed that the complex
formation facilitates the ubiquitination of a Lys residue located between the DLG and
ETGE motifs in sequence, leading to the degradation of Nrf247,50. Previous studies have
demonstrated that the ETGE motif of Nrf2 has a higher binding affinity (Ka, ETGE = 12.4 x
107 M-1) compared to the DLG (Ka, DLG = 2 x 106 M-1) motif for the Kelch domain47,50.
Our ITC results revealed that the binding affinity of ProTα (Ka = (3.8 ± 0.6) x 105 M-1)
was also significantly weaker than that of the Neh2 ETGE motif. Tong et al. reported that
the ΔH and TΔS of binding between Kelch and mouse Neh2 [Δ1-33] with the low affinity
DLG motif deleted were -21.2 and -10.2 kcal/mol, respectively47. Large and negative
values of ΔS are frequently observed for binding involving IDPs mainly due to the
significant reduction in conformational entropy58. Interestingly, compared to the
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thermodynamic parameters obtained in this study, the entropic penalty was lower for the
dynamic ProTα-Kelch complex formation (Table 1). On the other hand, the interaction
between ProTα and Kelch was weaker based on the values of the enthalpy changes.
Our peptide array result showed evidently that the 42ENGE45 motif is critical for
binding, since mutations in this region were disruptive. However, exceptions were seen.
Mutation of N43 to a Thr or Ser enhanced the binding to Kelch. Intriguingly, with the
ETGE motif, the Neh2 domain of Nrf2 has been shown to have a greater affinity for the
Kelch domain47. Therefore, conversion of the ENGE to an ETGE motif in ProTα
resulting in a higher binding affinity is not unexpected. Based on the crystal structures of
ProTα-Kelch and Neh2-Kelch peptide-protein complexes, both the Asn in ProTα and the
Thr in Neh2 are not directly involved in the interaction with Kelch. Instead, the sidechains of each of these two amino acids play important roles in stabilizing the β-turn
conformation of the binding motif by forming hydrogen bonds with the peptide
backbone47,52. This finding explains why the N43S mutant of ProTα also showed Kelch
binding affinity that is similar to N43T, as the hydroxyl group of Ser may still participate
in the intra-molecular hydrogen bonding47,52. Notably, hydrogen bonds between the N/N
and D/T pairs in the 40NEEN43 and 77DEET80 motifs of ProTα and Neh2, respectively,
also contribute to stabilization of the β-turn conformation of these proteins in their free
states65,66.
Meanwhile, the binding affinity between ProTα and Kelch increased by 5-fold
when E41, the residue N-terminal to the ENGE motif, of ProTα was mutated to a Pro
residue (Ka = 19.2 ± 0.8 x 105 M-1). One possible explanation for the higher affinity of the
ProTα E41P mutant is that the conformational entropy of the free state is reduced,
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lowering the amount of entropic penalty upon binding. The 40NEENGE45 region of
ProTα adopts β-turn conformations when bound to the Kelch domain52,88. Pro residues
are commonly found in position i+1 of β-turns in proteins89. The cyclic side chain of Pro
leads to drastic restriction in the sampling of backbone dihedral angles. Our MD
simulation of the E41P peptide (in its free state) suggested that it has a high tendency to
form the bound-state-like β-turn structure. Therefore, it seems plausible that the
incorporation of a Pro at this position leads to a less severe conformational entropy loss
upon binding, resulting in a higher binding affinity. Indeed, lowered free state
conformational entropy is thought to play an important role in the high affinity of the
Neh2-Kelch domain interaction50,65. Another possible explanation is that, since E41 is
involved in forming salt bridges and hydrogen bonds across the binding interface with
Kelch, mutating this residue to a non-polar Pro would result in loss of these interactions.
The change would render this region of the protein more flexible, thus lowering the
reduction in conformational entropy of the system upon binding.
Intriguingly, p62, a protein involved in regulation of autophagy, was recently
found to bind to the Kelch domain of Keap190. Crystal structures show that ProTα, p62,
and Neh2 all interact with the same site on the Kelch domain47,52,90. Even though the
Kelch-binding motif in p62, 350PSTGE354, differs from the 41EENGE45 and 78EETGE82
motifs of ProTα and Neh2, respectively, the Gly and Glu residues at the 4th and 5th
positions are conserved. This observation is consistent with our results that these two
residues are crucial for the interaction with Kelch 47,52,90. Interestingly, the corresponding
E41 in ProTα is replaced with a Pro residue in p6290. ITC experiments performed by
Komatsu et al. show that the binding affinity of p62 for Kelch is Ka = 5.4 ± 0.3 x 105 M-
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1 90

, which is slightly higher than what was determined for ProTα and Kelch (Ka = 3.8 ±

0.6 x 105 M-1).
E47 is another residue in ProTα that may help to stabilize the bound-state βhairpin structure. Our ITC results (Table 1) revealed that mutation of this residue to an
Ala or Arg decreased the binding affinity to Kelch by 55 fold, and ~10 fold, respectively.
Since the side-chain of the corresponding Glu was invisible in the crystal structure of
mouse ProTα-Kelch peptide-protein complex52, it is unclear whether this residue was
involved in any intra- or intermolecular interactions. We speculate that the side-chain of
E47 may be involved in intra-molecular hydrogen bonding with N38, and the interaction
can still be retained in the E47R mutant. The transient interaction between these two
residues may also help to stabilize the bound-state-like β-hairpin structure in the free state
of ProTα.
We also conclude from our NMR and ITC experiments that even though peptides
can be used to mimic specific regions of a protein when studying binding, the target
recognition mechanisms of peptides can differ from that of the full-length protein. As
seen in Table 1, although the ProTα peptide and protein had similar binding affinities to
Kelch, their ΔH and ΔS values differed. Based on the observed chemical shift changes of
ProTα upon target binding and the spin relaxation parameters determined in both the free
and bound-states, only residues around the binding motif were involved in the interaction
with Kelch while the rest of the protein remained highly disordered. One possible
explanation for the significant differences in the ΔH and ΔS values is that a greater loss in
the conformational entropy of the peptide occurred upon binding to Kelch. This idea is in
agreement with our earlier computational study of the free-state structure of full-length
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ProTα and peptide using MD simulations65. In that work, we had demonstrated that the
full-length ProTα has a higher propensity than the peptide in forming the bound-state-like
β-hairpin structure, which can result in a less entropic penalty upon coupled binding and
folding for the full-length protein. On the other hand, the enthalpy change of the ProTα
peptide is more negative compared to the full-length protein. Since the measured ΔH is
the sum of the enthalpy changes due to the binding and folding processes, the larger ΔH
value of the peptide is likely due to the folding from the less bound-state-like
conformations.
Despite the highly dynamic nature of disordered proteins, it has been generally
accepted that they will adopt a well-defined structure once bound to the target, at least in
the regions that are directly involved in the interaction. Several recent examples,
however, challenge this view and suggest that disordered proteins can still be flexible
even in the bound states67-69. For instance, the disordered cyclin-dependent kinase
inhibitor Sic1 does not undergo a disorder-to-order transition upon binding to Cdc491.
Instead, NMR studies showed that the multiple and dispersed phosphorylated motifs on
Sic1 interact with a single binding site on Cdc4 in a dynamic equilibrium manner. This
unusual binding mechanism has been proposed to lead to the ultrasensitivity to
phosphorylation, which is crucial for the function of Sic1 in cell cycle regulation91.
Another example of a fuzzy complex is the dynamic interaction between clathrin
assembly protein AP180 and clathrin69. NMR studies demonstrated that a large fragment
of the clathrin binding domain (CBD) of AP180 is disordered. Interestingly, this protein
fragment remains unstructured even in the bound form with clathrin. This dynamic
binding mode was speculated to be important for the assembly of the clathrin lattice69.
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In summary, our results here show that only a small region of the highly
disordered ProTα is involved in the interaction with the Kelch domain, and the protein
does not undergo large conformational change upon binding. These properties may allow
ProTα to also interact with other targets simultaneously. In addition, the fuzzy complex
formed between the two proteins is probably what allows ProTα to quickly dissociate
from Keap1 after the latter is translocated into the nucleus38.
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Materials and Methods
Protein Expression and Purification
The expression and purification of human ProTα was reported previously77. The
pET15b plasmid carrying the human Kelch cDNA, a kind gift from Dr. Mark Hannink at
the University of Missouri-Columbia, was transformed into E. coli BL21 (DE3) cells
(Novagen). The protein was overexpressed in M9 minimal media and induced by adding
0.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG; Bioshop). After 18 h induction at
16 °C, the bacteria were harvested and stored at -20 °C. The His-tagged protein was
purified by affinity chromatography using Ni-Sepharose 6 FF beads (Amersham
Biosciences). The eluted protein was dialyzed against TE buffer (20 mM Tris-HCl, 1 mM
EDTA, 1 mM DTT, 100 mM NaCl). The His-tag was cleaved with human alphathrombin (Haematologic Technologies), and protein was further purified with HiLoad
Superdex 75 column (GE Healthcare). The final protein sample was dialyzed in 50 mM
sodium phosphate buffer, 100 mM NaCl, 1 mM DTT, pH 7.

Peptide synthesis
The ProTα peptide (98% in purity), 38NANEENGEQEA48 was ordered from
GenScript USA Inc. The lyophilized peptide was dissolved in 50 mM Sodium phosphate
buffer, 100 mM NaCl, 1 mM DTT for ITC and NMR experiments.

Site-directed mutagenesis of wild-type ProTα
Wild-type ProTα in pET15b plasmid was subjected to point mutagenesis using
the Stratagene Quikchange II site-directed mutagenesis kit. The primers used for each
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point mutation are included in Supplemental data. Over expression and purification of
mutant variants of ProTα were carried out with the similar procedure used for the wildtype ProTα77.

NMR spectroscopy
All NMR experiments (except the amide hydrogen exchange experiments) were
performed on a Varian Inova 600MHz spectrometer equipped with xyz-gradient triple
resonance probe at 25 °C in buffer containing 50 mM sodium phosphate, 100 mM NaCl,
1 mM DTT, and 10% (v/v) D2O (Cambridge Isotope Laboratories). 1 mM of sodium 2, 2dimethyl-2-silapentane-5-sulfonate (DSS, Sigma) was added to each NMR sample as an
internal standard for the chemical shift referencing92. All NMR data were analyzed with
NMRPipe93, and the spectra were analyzed with NMRView94.
For the NMR titration experiments, unlabeled Kelch was titrated into 600 µL of
150 µM 15N-labeled ProTα until a 1:2 molar ratio (ProTα : Kelch) point was reached.
1

H-15N HSQC spectra were collected for each titration point.
The TROSY-HSQC spectra of Kelch was collected with 200 µM 15N-labeled

sample. Unlabelled full-length ProTα and ProTα peptide (residues 33-52) were added to
achieve a final concentration of 1:2 molar ratio of Kelch to ProTα.
Backbone 15N longitudinal relaxation rates (R1), relaxation rates in rotating frame
(R1ρ), and steady-state 1H-15N NOE relaxation parameters of 150 µM 15N-labeled ProTα
were measured in both the free state and the Kelch bound state (unlabeled 300 µM Kelch)
using identical parameters as described previously10.
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Amide hydrogen exchange (HX) rate measurements were performed at 25 oC on a
Bruker Avance 800 MHz spectrometer equipped with cryogenic probe (National
University of Singapore) using the method recently proposed by Fan et al.84. The HX
rates of 15N-labeled ProTα (180 µM) were measured in both the free state and the Kelchbound state (unlabeled 450 µM Kelch) using the following mixing times: 20, 30, 40, 50,
60, 70, 80, 90, 100, 120, 140, 160, 190, 220, 260, and 300 ms. For each mixing time, data
sets with and without the suppression of radiation damping were collected in interleaved
manner and each FID was acquired with 6 scans. A reference spectrum was collected for
each sample using a long interscan delay (10 s) and by removing the first 1H pulse and
the mixing period in the pulse sequence as mentioned in the reference84. The data were
processed using NMRPipe93. For each isolated peak, signal intensities were fitted to
Equation 1 (Equation 9 in the reference84) in order to determine the exchange rates.
(1)

where f is the fractional steady-state water magnetization; R1H is the relaxation rate of an
amide proton; Iref is the equilibrium magnetization of the amide proton, which is equal to
two times of the peak intensity of the amide in the reference spectrum when it is recorded
with the same number of scans as the other spectra; IEX(t) is the peak intensity of the
amide correlation at mixing time t, which is obtained from the difference spectrum of two
interleaved data sets; t0 is the latency interval; and R1w is the longitudinal relaxation rate
of water. In the data fitting, f, t0, and R1w were set to 0.90, 17.4 ms, and 0.3 s-1,
respectively. The protection factor (P) of the backbone amide proton of each amino acid
was calculated as the ratio of the intrinsic HX rate (kint) of random coil to the
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experimentally determined HX rate. The kint values were estimated with SPHERE web
server (http://www.fccc.edu/research/labs/roder/sphere/sphere.html)95,96.

Isothermal titration calorimetry (ITC)
ITC experiments were carried out on a MicroCalTM VP-ITC. All purified protein
samples were dialyzed into 50 mM sodium phosphate, 100 mM NaCl, 1 mM DTT at pH
7.0. For titrations, purified Kelch and ProTα were prepared to 60 µM and 790 µM,
respectively, in dialysis buffer, and each was degassed prior to titration. Kelch was
loaded into the 1.42 mL cell, and ProTα was loaded into the syringe (300 µL). Titrations
were performed at 25 °C starting with initial injection of 3 µL, followed by 59 larger
injections of 5 µL, with spacing of 360 s (except for the ProTα peptide with spacing of
120 s). The sample cell was stirred at 300 rpm throughout the experiment. The buffer
blank was performed under the same conditions and showed negligible heats of binding.
The dissociation constant (Kd), stoichiometry of binding (N), binding enthalpy (ΔH), and
entropy (ΔS) were obtained by non-linear least squares fitting of the data to a single-site
binding model provided with the data analysis software (Origin 7). Baselines were
subtracted from final data using Origin software. All protein concentrations were
determined using Lowry (for ProTα) and Bradford (for Kelch) assays. Protein
concentrations were confirmed by amino acid analysis (Advanced Protein Technology
Centre, The Hospital for Sick Children, Toronto, ON).

Peptide array
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A twenty-residue, 38NANEENGEQEADNEVDEEEE57, ProTα peptide spot array
was ordered from the Peptide and Peptide Array Synthesis Facility at the University of
Western Ontario. The peptide membrane was hydrated, blocked with 5% skim milk, and
then probed with the Kelch domain of Keap1. His Probe-HRP was used to detect the
ProTα peptide-Kelch interaction. The membrane was developed with the ECL
Lightening Plus kit (Perkin Elmer, Mississauga, ON) before exposing to film.

MD simulations
Several MD simulations were performed in order to gain further insight into the
bound and free state dynamics of of ProTα and the Neh2 domain of Nrf2. These included
simulations of ProTα and the Neh2 domain in complex with the Kelch domain of Keap1
and free state simulations of a 16-mer ProTα peptide and the E41P mutant. All MD
simulations were performed using GROMACS version 497and the GROMOS96 53a698,99
force field.
The starting structures for the bound state simulations were based upon the crystal
structures of mouse ProTα and Neh2 domain peptides bound to the mouse Kelch domain
(PDB ids: 2Z32 and 1X2R, respectively)52,54. The rest of the full-length mouse ProTα
and Neh2 domain (residues 1-100) were modeled onto these crystal structures. Detailed
description of the generation of bound state complexes and the parameters used for the
MD simulations are included in Supplemental Data. The simulations were run for 300 ns
each.
The starting structures for the free state simulations of the 16-mer ProTα peptide
and the E41P mutant were generated using the Crystallography & NMR System (CNS)100
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to generate an extended structure based solely upon the amino acid sequence of a 16-mer
human isoform 2 ProTα peptide, 35ANGNANEENGEQEADN50, and its E41P mutational
variant, 35ANGNANPENGEQEADN50. Annealing simulations were then performed to
relax the fully extended conformation. Unstructured conformations of each peptide from
the annealing simulations were used as the starting structures for the MD simulations,
which were performed using similar parameters as the bound state simulations. The
peptides were centered in boxes large enough so that the minimum distance to the box
edge was > 1.0 nm. The systems contained 7620 water molecules, 19 Na+ and 14 Cl- ;
8513 waters, 20 Na+ and 16 Cl- for the wild-type and E41P mutational variant peptide,
respectively. The simulations were run for 500 ns each.
Residue specific dynamics of the ProTα and Neh2 in bound states were analyzed
based on the circular variance (C.V.) of the φ and ψ dihedral angles over time. The C.V. is
defined as101
(2)
where m is the number of structures included in the analysis, and R is calculated using the
following equation:
(3)
The value of C.V. ranges between 0 and 1. The higher the C.V. values, the larger are the
φ and ψ variability.
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Figure Legends
Figure 1. NMR titration experiments of ProTα with Kelch. (a) 1H-15N HSQC spectra
of ProTα alone (blue) and with 2 equivalents of Kelch domain (red). Close-up views of
the 1H-15N HSQC spectra, showing selected chemical shift changes during the titration,
are shown. (b) SSP scores for ProTα in the free (blue) and bound state with Kelch (red),
calculated using 13Cα and 13Cβ chemical shifts. Residues for which SSP scores were not
calculated are represented by a tick mark. The regions showing significant changes in
SSP correspond to peaks on the HSQC spectrum that undergo large chemical shift
changes.
Figure 2. Backbone 15N relaxation experiments of ProTα in the free (blue) and
bound state with 2 equivalents of Kelch (red). (a) R1 (longitudinal) relaxation rate. (b)
R2 (transverse) relaxation rate. (c) steady-state 1H-15N NOE.
Figure 3. Protection factor (P) of backbone amides in ProTα in the absence (blue
bars) and presence of Kelch (red *). The P value of each amino acid was calculated as
the ratio of the intrinsic HX rate (kint) of random coil to the experimentally determined
HX rate. The kint values were estimated using the SPHERE web server
(http://www.fccc.edu/research/labs/roder/sphere/sphere.html)95,96

Figure 4. Permutation peptide array experiments. 20-mer peptides of ProTα (residues
38-57) were immobilized on a cellulose membrane and then probed with the Kelch
domain of Keap1. The left column shows the wild-type sequence and positions of the
amino acids that were permutated (mutations specified at the top of second column). Cys
was excluded in the permutation to avoid false positives. The ‘+’ in the second column
indicates wt 20-mer sequence and is used as a positive control. Array was repeated twice.
Intensity of each permutation was qualitatively measured and compared to wild-type, and
results reported are based on what was observed consistently in the two arrays. Columns,
on the right side indicate amino acid residues that weaken, strengthen, or have no effect
on the binding affinity between the 20-mers and Kelch. As shown in the array, mutations
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in the EENGE motif are poorly tolerated. AA, amino acid; X, every amino acid except
Cys and those mentioned as weaker or stronger; wt, wild-type.
Figure 5. ITC profiles of Keap1 with full length ProTα and its mutant variants. (a)
Full length wild-type ProTα (b) EENGE ProTα 11-mer peptide (c) N36A (d) E41P (e)
G44A (f) E45G (g) E47A (h) E47R (i) E51G
Figure 6. Average circular variances from the Kelch-bound state of ProTα and of
Nrf2 MD simulations. The values were calculated as described by101 and averaged over
the last 200 ns (100-300 ns) of the trajectories. Values for the Kelch domain binding
domain and surrounding residues are shown.
Figure 7. Backbone rmsd’s between the bound state and MD structures. The rmsd
values were calculated by least-squares fitting the backbone atoms (N, Cα, and C) of the
NEEN or NPEN sequences from each frame to the corresponding atoms of bound state
reference structure (PDB id: 2Z32)52.
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Table 1

Table 1. Thermodynamic parameters for binding of the full-length ProTα, ProTα peptide, and
ProTα mutants to Kelch domain of Keap1 at 25 °C*
WT Kelch

n

Full length
1.06 ± 0.02
ProTα
ProTα Peptide 0.93 ± 0.00(4)
EENGE
N36A
E41P
E47A
E47R
D49A
E51A
E51G
*

Ka
(105 M-1)
3.8 ± 0.6

Kd
(µM)
2.6 ± 0.4

ΔH
(kcal/mol)
-14.8 ± 0.4

TΔS
(kcal/mol)
-7.19

ΔG
(kcal/mol)
-7.61 ± 0.09

5.6 ± 0.3

1.79 ± 0.09

-22.6 ± 0.1

-14.76

-7.84 ± 0.03

-3.03
-5.60
-9.96
-6.94
-5.53
-5.80
-8.21

-7.07 ± 0.02
-8.57 ± 0.02
-5.24 ± 0.05
-6.16 ± 0.05
-7.07 ± 0.08
-6.90 ± 0.03
-7.02 ± 0.02

0.95 ± 0.00(5) 1.53 ± 0.05
6.5 ± 0.2
-10.1 ± 0.6
1.10 ± 0.00(2) 19.2 ± 0.8
0.52 ± 0.02 -14.17 ± 0.04
1.08 ± 0.16 0.069 ± 0.006 145 ± 13
-15.2 ± 0.3
0.93 ± 0.09
0.33 ±0.03
30 ± 3
-13.1 ± 0.2
1.04 ± 0.02
1.5 ± 0.2
6.7 ± 0.9
-12.6 ± 0.3
1.06 ± 0.01
1.14 ± 0.05
8.8 ± 0.4
-12.7 ± 0.2
1.04 ± 0.01
1.40 ± 0.06
7.1 ± 0.3 -15.23 ± 0.02

n is the stoichiometry, Ka, and Kd are the association and dissociation constants, respectively.
ΔG = -RTlnKa, where T is the temperature in Kelvin, R is the gas constant. ΔH and ΔS are the
enthalpy and entropy changes, respectively. Each experiment was repeated twice; the values
obtained between the two runs were similar. Values listed in the tables are based on one run, and
the data for the duplicate run is provided in the supplementary data (Table S2).

Supplemental Data

Figure S1. Predictions of disorder propensity and potential binding sites for ProTα.
PONDR-FIT75 (red) and metaPRDOS76 (green) plots analyzing disorder nature of
ProTα. ANCHOR78 and MoRFpred79 analysis of potential binding sites in ProTα. The
blue line represents the predicted binding site by ANCHOR, and the pink line represents
the predicted binding interface by MoRFpred.

Figure S2. 1H–15N TROSY-HSQC spectra of the human Kelch domain of Keap1 (black).
Overlay of the Kelch spectra in the presence of the full-length human ProTα (red) and
ProTα peptide (cyan), 33APANGNANEENGEQEADNEV52.

Residuals

Figure S3. Sedimentation equilibrium analysis of Kelch and ProTα binding. Pure Kelch
protein at a concentration of 10 µM was centrifuged with various concentrations of
ProTα (to achieve a ratio of 1:0.5, 1:1, and 1:2 with the Kelch domain) at 4°C at 22 000
rpm. The upper panel represents the residual values for the fits.

Figure S4. Snapshots from the A) Kelch-ProTα and B) Kelch-Neh2 domain MD
simulations. Conformations captured at t=50, 100, 150, 200, 250 and 300 ns are shown.
The regions correspond to the bound-state β-turn structure are circled. Cluster center
structures illustrate molecular detail of the binding interfaces.

Figure S5. Snapshots from the free state MD simulations of the A) wild type ProTα
peptide and B) E41P ProTα peptide.

Table S1. Molecular weight values of Kelch calculated from the sedimentation
equilibrium experiment.
Protein
Kelch

Concentration
(µM)
10

Kelch

10

ProT α
Kelch
ProT α
Kelch
ProT α

Calculated MW
(Da)
33915.85

Observed MW
(Da)
34565 ± 338

39952.76

41551 ± 331

45989.67

44978 ± 396

45989.67

46793 ± 379

5
10
10
10
20

Table S2. Thermodynamic parameters for binding of the ProTα peptide, full-length ProTα and
its mutants to Kelch domain of Keap1 at 25 °C (second set)
WT Kelch
n
Ka
Kd
ΔH
TΔS
ΔG
5
-1
(10 M )
(µM)
(kcal/mol)
(kcal/mol)
(kcal/mol)
Full length
1.04 ± 0.02
3.3 ± 0.3
3.04 ± 0.2 -15.5 ± 0.4
-7.97
-7.53 ± 0.05
ProTα
ProTα Peptide 1.13 ± 0.004
5.7 ± 0.3
1.74 ± 0.08 -23.1 ± 0.1
-15.24
-7.86 ± 0.03
EENGE
N36A
0.95 ± 0.04
1.6 ± 0.5
6.1 ± 1.8
-9.9 ± -0.5
-2.8
7.1 ± 0.2
E41P
1.16 ± 0.002
20.3 ± 0.8
0.49 ± 0.02 -15.05 ± 0.05
-6.45
-8.60 ± 0.02
E47A
1.10 ± 0.12 0.061 ± 0.002
164± 5
-15.9 ± 0.2
-10.74
-5.16 ± 0.02
E47R
0.91 ± 0.04 0.303 ± 0.02
33 ± 2
-13.20 ± 0.08
-7.09
-6.11 ± 0.03
D49A
1.06 ± 0.05
2.2 ± 0.8
4.5 ± 1.6
-12.0 ± 0.7
-4.7
-7.3 ± 0.2
E51A
0.95 ± 0.01
1.18 ± 0.06
8.5 ± 0.4
-13.2 ± 0.2
-6.28
-6.92 ± 0.03
E51G
1.05 ± 0.01
1.49 ± 0.05
6.7 ± 0.2 -15.63 ± 0.02
-8.57
-7.06 ± 0.02
*
n is the stoichiometry, Ka, and Kd are the association and dissociation constants, respectively.
ΔG =-RTlnKa=ΔH-TΔS, where T is the temperature and R is the gas constant. ΔH and ΔS are the
enthalpy and entropy changes, respectively.

Materials and Methods
Analytical ultracentrifugation
Analytical ultracentrifugation technique was employed to determine the binding
stoichiometry of ProTα to the Kelch domain of Keap1. Sedimentation equilibrium
experiments were performed in a Beckman-Coulter Optima XL-A analytical
ultracentrifuge (Beckman Coulter, Palo Alto, CA) with an AN60Ti rotor. Six-sector
Epon-charcoal centerpieces with quartz windows were used. Protein samples were
dialyzed in 50 mM phosphate, 100 mM NaCl, 1 mM DTT, at pH 7.0. Data were
collected at 22,000 rpm following 24 h equilibration period at 4°C. Kelch absorbance at
280 nm was measured with 10 replicates with a step size of 0.002 cm. Data were fitted
to a single species model using Microsoft Origin 7.0 software. Partial specific volume
for Kelch was calculated to be 0.7219 mL/g based on the amino acid composition. The
solvent density was measured to be 1.008 g/mL. Protein concentrations were calculated
by protein quantification methods:, Lowry for ProTα and Bradford assay for Kelch, as
well as by amino acid analysis (Advanced Protein Technology Centre, The Hospital for
Sick Children, Toronto, ON).

Primers used for point mutations.
E41P: 5’ CCCTGCTAACGGGAATGCTAATCCGGAAAATGGGGAGC 3’
E45G: 5’ TAATGAGGAAAATGGGGGGCAGGAGGCTGACAATG 3’
E45A: 5’ TAATGAGGAAAATGGGGCGCAGGAGGCTGACAATG 3’
E51A: 5’ CAGGAGGCTGACAATGCGGTAGACGAAGAAGAG 3’

E51G: 5' CAGGAGGCTGACAATGGGGTAGACGAAGAAGAG 3'
E47A: 5' GAAAATGGGGAGCAGGCGGCTGACAATGAGGTA 3'
E47R: 5' GAGGAAAATGGGGAGCAGCGCGCTGACAATGAGGTAGAC 3'
D49A: 5' GGAGCAGGAGGCTGCCAATGAGGTAGACG 3'
N36A: 5' ATGGAAGAGACGCCCCTGCTGCCGGGAATGCTAATG 3'
G44A: 5' GGAATGCTAATGAGGAAAATGCGGAGCAGGAGGCTG 3'

MD Simulations
Generation of bound-state complexes
The ProTα coordinates were obtained from a previously reported free state
simulation in which bound-state-like hairpin structures were observed52. This step
allowed for straightforward modeling of the full-length protein onto the existing crystal
structure coordinates52. For the Neh2 domain, we used the Crystallography & NMR
System (CNS)100 to generate an extended structure based solely upon amino acid
sequence and performed simulated annealing simulations in which dihedral angle
restraints were applied to force residues 39-71 into a helical conformation47. A structure
from the annealing simulations was pre-equilibrated using unrestrained MD in explicit
solvent for several hundred ns. During this simulation, hairpin formation in the Kelch
binding region occurred, and the central helix remained largely intact. We proceeded to
model the Neh2 domain coordinates from this system onto the existing crystal structure
coordinates54. When modeling the complexes, the protein coordinates from the crystal
structures52,54 were used in their complete and unmodified forms, with the exception of
the addition of N- and C-terminal acetyl (ACE) and NH2 capping groups, respectively, to

the Kelch and Neh2 domains. The bound-state complexes were pre-equilibrated for 130
ns each in explicit solvent before production runs. Both the ProTα-Kelch domain and
Nrf2-Kelch domain complexes remained intact (did not dissociate) throughout
equilibration.

Parameters for MD simulations
After a 130 ns equilibration of each system in explicit solvent, a production
simulation was performed. The protonation states of ionizable amino acids were chosen
based upon their most probable charge at pH 7. Cys side-chains were always protonated,
and His side-chain protonation states were determined automatically by GROMACS97,
based upon their local hydrogen bonding geometry. Cubic boxes with side lengths of 11
and 10 nm were used for the ProTα and Neh2 systems, respectively. Water molecules
were replaced with sodium (Na+) and chloride (Cl-) ions as necessary to neutralize the
system charges and reach a physiological salt concentration to 0.1 M. The ProTα-Kelch
domain system contained 41812 water molecules, 130 Na+ and 80 Cl-. The Neh2 domainKelch domain system contained 31022 water molecules, 78 Na+ and 60 Cl-. The protein
and non-protein atoms were coupled to separate temperature baths, maintained at 310 K
using the Parrinello-Bussi algorithm102. The pressure was maintained isotropically at 1
bar using the Parrinello-Rahman barostat103. A 2-fs timestep was employed. Periodic
boundary conditions were applied in all directions. Before production runs, the energy of
each system was minimized using the steepest descents algorithm, followed by 2 ps of
position-restrained dynamics with all non-hydrogen atoms restrained with a 1000 kJ mol1

force constant. The atom velocities were assigned from a Maxwellian distribution at 310

K. Bond lengths were constrained using the LINCS algorithm104. The cut-off for
Lennard-Jones interactions was 1.0 nm. Dispersion corrections for energy and pressure
were applied. The Particle-Mesh Ewald (PME) method105, with 0.12 nm grid-spacing and
a 1.0 nm real-space cut-off, was used for electrostatics. The simulations were run for 300
ns each and the last 200 ns were used for circular variance analysis.

